16 results on '"Zondler, Lisa"'
Search Results
2. Peripheral monocytes are functionally altered and invade the CNS in ALS patients
- Author
-
Zondler, Lisa, Müller, Kathrin, Khalaji, Samira, Bliederhäuser, Corinna, Ruf, Wolfgang P., Grozdanov, Veselin, Thiemann, Meinolf, Fundel-Clemes, Katrin, Freischmidt, Axel, Holzmann, Karlheinz, Strobel, Benjamin, Weydt, Patrick, Witting, Anke, Thal, Dietmar R., Helferich, Anika M., Hengerer, Bastian, Gottschalk, Kay-Eberhard, Hill, Oliver, Kluge, Michael, Ludolph, Albert C., Danzer, Karin M., and Weishaupt, Jochen H.
- Published
- 2016
- Full Text
- View/download PDF
3. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
- Author
-
Bliederhaeuser, Corinna, Grozdanov, Veselin, Speidel, Anna, Zondler, Lisa, Ruf, Wolfgang P., Bayer, Hanna, Kiechle, Martin, Feiler, Marisa S., Freischmidt, Axel, Brenner, David, Witting, Anke, Hengerer, Bastian, Fändrich, Marcus, Ludolph, Albert C., Weishaupt, Jochen H., Gillardon, Frank, and Danzer, Karin M.
- Published
- 2016
- Full Text
- View/download PDF
4. Impaired activation of ALS monocytes by exosomes
- Author
-
Zondler, Lisa, Feiler, Marisa S, Freischmidt, Axel, Ruf, Wolfgang P, Ludolph, Albert C, Danzer, Karin M, and Weishaupt, Jochen H
- Published
- 2017
- Full Text
- View/download PDF
5. Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
- Author
-
Grozdanov, Veselin, Bliederhaeuser, Corinna, Ruf, Wolfgang P., Roth, Valerie, Fundel-Clemens, Kathrin, Zondler, Lisa, Brenner, David, Martin-Villalba, Ana, Hengerer, Bastian, Kassubek, Jan, Ludolph, Albert C., Weishaupt, Jochen H., and Danzer, Karin M.
- Published
- 2014
- Full Text
- View/download PDF
6. CNS Pericytes Modulate Local T Cell Infiltration in EAE.
- Author
-
Koch, Kathrin, Lindner, Maren, Fleck, Ann-Katrin, Liebmann, Marie, Eschborn, Melanie, Zondler, Lisa, Diéguez-Hurtado, Rodrigo, Adams, Ralf H., Meyer zu Hörste, Gerd, Zarbock, Alexander, Kuhlmann, Tanja, Wiendl, Heinz, and Klotz, Luisa
- Subjects
BLOOD-brain barrier ,PERICYTES ,T cells ,MAJOR histocompatibility complex ,CENTRAL nervous system ,CELL physiology ,ENDOTHELIAL cells - Abstract
Pericytes at the blood–brain barrier (BBB) are located between the tight endothelial cell layer of the blood vessels and astrocytic endfeet. They contribute to central nervous system (CNS) homeostasis by regulating BBB development and maintenance. Loss of pericytes results in increased numbers of infiltrating immune cells in the CNS in experimental autoimmune encephalomyelitis (EAE), the mouse model for multiple sclerosis (MS). However, little is known about their competence to modulate immune cell activation or function in CNS autoimmunity. To evaluate the capacity of pericytes to directly interact with T cells in an antigen-specific fashion and potentially (re)shape their function, we depleted major histocompatibility complex (MHC) class II from pericytes in a cell type-specific fashion and performed T cell-pericyte cocultures and EAE experiments. We found that pericytes present antigen in vitro to induce T cell activation and proliferation. In an adoptive transfer EAE experiment, pericyte-specific MHC II KO resulted in locally enhanced T cell infiltration in the CNS; even though, overall disease course of mice was not affected. Thus, pericytes may serve as non-professional antigen-presenting cells affecting states of T cell activation, thereby locally shaping lesion formation in CNS inflammation but without modulating disease severity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Serum microRNAs in sporadic amyotrophic lateral sclerosis
- Author
-
Freischmidt, Axel, Müller, Kathrin, Zondler, Lisa, Weydt, Patrick, Mayer, Benjamin, von Arnim, Christine A.F., Hübers, Annemarie, Dorst, Johannes, Otto, Markus, Holzmann, Karlheinz, Ludolph, Albert C., Danzer, Karin M., and Weishaupt, Jochen H.
- Published
- 2015
- Full Text
- View/download PDF
8. MCAM/CD146 Signaling via PLCγ1 Leads to Activation of β1-Integrins in Memory T-Cells Resulting in Increased Brain Infiltration.
- Author
-
Zondler, Lisa, Herich, Sebastian, Kotte, Petra, Körner, Katharina, Schneider-Hohendorf, Tilman, Wiendl, Heinz, Schwab, Nicholas, and Zarbock, Alexander
- Subjects
T cells ,CELL adhesion molecules ,CENTRAL nervous system diseases ,CENTRAL nervous system ,INTEGRINS ,PSYCHONEUROIMMUNOLOGY - Abstract
Multiple sclerosis is a chronic auto-inflammatory disease of the central nervous system affecting patients worldwide. Neuroinflammation in multiple sclerosis is mainly driven by peripheral immune cells which invade the central nervous system and cause neurodegenerative inflammation. To enter the target tissue, immune cells have to overcome the endothelium and transmigrate into the tissue. Numerous molecules mediate this process and, as they determine the tissue invasiveness of immune cells, display great therapeutic potential. Melanoma cell adhesion molecule (MCAM) is a membrane-anchored glycoprotein expressed by a subset of T-cells and MCAM+ T-cells have been shown to contribute to neuroinflammation in multiple sclerosis. The role of the MCAM molecule for brain invasion, however, remained largely unknown. In order to investigate the role of the MCAM molecule on T-cells, we used different in vitro and in vivo assays, including ex vivo flow chambers, biochemistry and microscopy experiments of the mouse brain. We demonstrate that MCAM directly mediates adhesion and that the engagement of MCAM induces intracellular signaling leading to β1-integrin activation on human T-cells. Furthermore, we show that MCAM engagement triggers the phosphorylation of PLCγ1 which is required for integrin activation and thus amplification of the cellular adhesive potential. To confirm the physiological relevance of our findings in vivo , we demonstrate that MCAM plays an important role in T-cell recruitment into the mouse brain. In conclusion, our data demonstrate that MCAM expressed on T-cells acts as an adhesion molecule and a signaling receptor that may trigger β1-integrin activation via PLCγ1 upon engagement. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
9. Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis.
- Author
-
Herich, Sebastian, Schneider-Hohendorf, Tilman, Rohlmann, Astrid, Ghadiri, Maryam Khaleghi, Schulte-Mecklenbeck, Andreas, Zondler, Lisa, Janoschka, Claudia, Ostkamp, Patrick, Richter, Jannis, Breuer, Johanna, Dimitrov, Stoyan, Rammensee, Hans-Georg, Grauer, Oliver M, Klotz, Luisa, Gross, Catharina C, Stummer, Walter, Missler, Markus, Zarbock, Alexander, Vestweber, Dietmar, and Wiendl, Heinz
- Subjects
MEMORY ,BLOOD cells ,T cells ,BLOOD-brain barrier ,CELLS ,MULTIPLE sclerosis ,JOHN Cunningham virus ,MENTAL health ,EPILEPSY & psychology ,RESEARCH ,AIDS dementia complex ,EPILEPSY ,RESEARCH methodology ,PROTEOLYTIC enzymes ,CELL receptors ,EVALUATION research ,MEDICAL cooperation ,CELL motility ,COMPARATIVE studies ,PSYCHOLOGICAL tests ,QUESTIONNAIRES ,CELLULAR immunity ,EPITHELIAL cells ,PSYCHOLOGICAL adaptation ,ANTIGENS - Abstract
Although the CNS is immune privileged, continuous search for pathogens and tumours by immune cells within the CNS is indispensable. Thus, distinct immune-cell populations also cross the blood-brain barrier independently of inflammation/under homeostatic conditions. It was previously shown that effector memory T cells populate healthy CNS parenchyma in humans and, independently, that CCR5-expressing lymphocytes as well as CCR5 ligands are enriched in the CNS of patients with multiple sclerosis. Apart from the recently described CD8+ CNS tissue-resident memory T cells, we identified a population of CD4+CCR5high effector memory cells as brain parenchyma-surveilling cells. These cells used their high levels of VLA-4 to arrest on scattered VCAM1, their open-conformation LFA-1 to crawl preferentially against the flow in search for sites permissive for extravasation, and their stored granzyme K (GZMK) to induce local ICAM1 aggregation and perform trans-, rather than paracellular diapedesis through unstimulated primary brain microvascular endothelial cells. This study included peripheral blood mononuclear cell samples from 175 healthy donors, 29 patients infected with HIV, with neurological symptoms in terms of cognitive impairment, 73 patients with relapsing-remitting multiple sclerosis in remission, either 1-4 weeks before (n = 29), or 18-60 months after the initiation of natalizumab therapy (n = 44), as well as white matter brain tissue of three patients suffering from epilepsy. We here provide ex vivo evidence that CCR5highGZMK+CD4+ effector memory T cells are involved in CNS immune surveillance during homeostasis, but could also play a role in CNS pathology. Among CD4+ T cells, this subset was found to dominate the CNS of patients without neurological inflammation ex vivo. The reduction in peripheral blood of HIV-positive patients with neurological symptoms correlated to their CD4 count as a measure of disease progression. Their peripheral enrichment in multiple sclerosis patients and specific peripheral entrapment through the CNS infiltration inhibiting drug natalizumab additionally suggests a contribution to CNS autoimmune pathology. Our transcriptome analysis revealed a migratory phenotype sharing many features with tissue-resident memory and Th17.1 cells, most notably the transcription factor eomesodermin. Knowledge on this cell subset should enable future studies to find ways to strengthen the host defence against CNS-resident pathogens and brain tumours or to prevent CNS autoimmunity. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Proteasome impairment by α-synuclein.
- Author
-
Zondler, Lisa, Kostka, Marcus, Garidel, Patrick, Heinzelmann, Udo, Hengerer, Bastian, Mayer, Benjamin, Weishaupt, Jochen H., Gillardon, Frank, and Danzer, Karin M.
- Subjects
- *
PROTEASOMES , *ALPHA-synuclein , *PARKINSON'S disease , *DISEASE prevalence , *DOPAMINERGIC neurons , *NEUROCHEMISTRY - Abstract
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder worldwide and characterized by the loss of dopaminergic neurons in the patients’ midbrains. Both the presence of the protein α-synuclein in intracellular protein aggregates in surviving neurons and the genetic linking of the α-synuclein encoding gene point towards a major role of α-synuclein in PD etiology. The exact pathogenic mechanisms of PD development are not entirely described to date, neither is the specific role of α-synuclein in this context. Previous studies indicate that one aspect of α-synuclein-related cellular toxicity might be direct proteasome impairment. The 20/26S proteasomal machinery is an important instrument of intracellular protein degradation. Thus, direct proteasome impairment by α-synuclein might explain or at least contribute to the formation of intracellular protein aggregates. Therefore this study investigates direct proteasomal impairment by α-synuclein both in vitro using recombinant α-synuclein and isolated proteasomes as well as in living cells. Our experiments demonstrate that the impairment of proteasome activity by α-synuclein is highly dependent upon the cellular background and origin. We show that recombinant α-synuclein oligomers and fibrils scarcely affect 20S proteasome function in vitro, neither does transient α-synuclein expression in U2OS ps 2042 (Ubi(G76V)-GFP) cells. However, stable expression of both wild-type and mutant α-synuclein in dopaminergic SH-SY5Y and PC12 cells results in a prominent impairment of the chymotrypsin-like 20S/26S proteasomal protein cleavage. Thus, our results support the idea that α-synuclein in a specific cellular environment, potentially present in dopaminergic cells, cannot be processed by the proteasome and thus contributes to a selective vulnerability of dopaminergic cells to α-synuclein pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. LRRK2 contributes to monocyte dysregulation in Parkinson's disease.
- Author
-
Bliederhaeuser, Corinna, Zondler, Lisa, Grozdanov, Veselin, Ruf, Wolfgang P., Brenner, David, Melrose, Heather L., Bauer, Peter, Ludolph, Albert C., Gillardon, Frank, Kassubek, Jan, Weishaupt, Jochen H., and Danzer, Karin M.
- Subjects
- *
DARDARIN , *PARKINSON'S disease , *B cells - Abstract
The article presents a study which aims to determine the contribution of Leucine-rich repeat kinase 2 (LRRK2) the dysregulation of monocytes in Parkinson's disease (PD) using a comprehensive picture of LRRK2 levels in circulating monocyte subpopulations and the lymphoid B-cells in PD patients.
- Published
- 2016
- Full Text
- View/download PDF
12. α-synuclein interacts with SOD1 and promotes its oligomerization.
- Author
-
Helferich, Anika M., Ruf, Wolfgang P., Grozdanov, Veselin, Freischmidt, Axel, Feiler, Marisa S., Zondler, Lisa, Ludolph, Albert C., McLean, Pamela J., Weishaupt, Jochen H., and Danzer, Karin M.
- Subjects
PARKINSON'S disease ,AMYOTROPHIC lateral sclerosis ,NEURODEGENERATION ,SYNUCLEINS ,SUPEROXIDE dismutase ,OLIGOMERS - Abstract
Background: Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) are both neurodegenerative diseases leading to impaired execution of movement. α-Synuclein plays a central role in the pathogenesis of PD whereas Cu, Zn superoxide dismutase (SOD1) is a key player in a subset of familial ALS cases. Under pathological conditions both α-synuclein and SOD1 form oligomers and fibrils. In this study we investigated the possible molecular interaction of α-synuclein and SOD1 and its functional and pathological relevance. Results: Using a protein-fragment complementation approach and co-IP, we found that α-synuclein and SOD1 physically interact in living cells, human erythrocytes and mouse brain tissue. Additionally, our data show that disease related mutations in α-synuclein (A30P, A53T) and SOD1 (G85R, G93A) modify the binding of α-synuclein to SOD1. Notably, α-synuclein accelerates SOD1 oligomerization independent of SOD1 activity. Conclusion: This study provides evidence for a novel interaction of α-synuclein and SOD1 that might be relevant for neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers.
- Author
-
Freischmidt, Axel, Müller, Kathrin, Zondler, Lisa, Weydt, Patrick, Volk, Alexander E, Bozic, Anze Losdorfer, Walter, Michael, Bonin, Michael, Mayer, Benjamin, von Arnim, Christine A F, Otto, Markus, Dieterich, Christoph, Holzmann, Karlheinz, Andersen, Peter M, Ludolph, Albert C, Danzer, Karin M, Weishaupt, Jochen H, and Božič, Anže Lošdorfer
- Abstract
Knowledge about the nature of pathomolecular alterations preceding onset of symptoms in amyotrophic lateral sclerosis is largely lacking. It could not only pave the way for the discovery of valuable therapeutic targets but might also govern future concepts of pre-manifest disease modifying treatments. MicroRNAs are central regulators of transcriptome plasticity and participate in pathogenic cascades and/or mirror cellular adaptation to insults. We obtained comprehensive expression profiles of microRNAs in the serum of patients with familial amyotrophic lateral sclerosis, asymptomatic mutation carriers and healthy control subjects. We observed a strikingly homogenous microRNA profile in patients with familial amyotrophic lateral sclerosis that was largely independent from the underlying disease gene. Moreover, we identified 24 significantly downregulated microRNAs in pre-manifest amyotrophic lateral sclerosis mutation carriers up to two decades or more before the estimated time window of disease onset; 91.7% of the downregulated microRNAs in mutation carriers overlapped with the patients with familial amyotrophic lateral sclerosis. Bioinformatic analysis revealed a consensus sequence motif present in the vast majority of downregulated microRNAs identified in this study. Our data thus suggest specific common denominators regarding molecular pathogenesis of different amyotrophic lateral sclerosis genes. We describe the earliest pathomolecular alterations in amyotrophic lateral sclerosis mutation carriers known to date, which provide a basis for the discovery of novel therapeutic targets and strongly argue for studies evaluating presymptomatic disease-modifying treatment in amyotrophic lateral sclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Age Increases Monocyte Adhesion on Collagen.
- Author
-
Khalaji, Samira, Zondler, Lisa, KleinJan, Fenneke, Nolte, Ulla, Mulaw, Medhanie A., Danzer, Karin M., Weishaupt, Jochen H., and Gottschalk, Kay-E.
- Abstract
Adhesion of monocytes to micro-injuries on arterial walls is an important early step in the occurrence and development of degenerative atherosclerotic lesions. At these injuries, collagen is exposed to the blood stream. We are interested whether age influences monocyte adhesion to collagen under flow, and hence influences the susceptibility to arteriosclerotic lesions. Therefore, we studied adhesion and rolling of human peripheral blood monocytes from old and young individuals on collagen type I coated surface under shear flow. We find that firm adhesion of monocytes to collagen type I is elevated in old individuals. Pre-stimulation by lipopolysaccharide increases the firm adhesion of monocytes homogeneously in older individuals, but heterogeneously in young individuals. Blocking integrin αx showed that adhesion of monocytes to collagen type I is specific to the main collagen binding integrin αxβ2. Surprisingly, we find no significant age-dependent difference in gene expression of integrin αx or integrin β2. However, if all integrins are activated from the outside, no differences exist between the age groups. Altered integrin activation therefore causes the increased adhesion. Our results show that the basal increase in integrin activation in monocytes from old individuals increases monocyte adhesion to collagen and therefore the risk for arteriosclerotic plaques. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
15. Monocyte subtypes in ALS.
- Author
-
Zondler, Lisa, Müller, Kathrin, Grozdanov, Veselin, Bliederhäuser, Corinna, Weydt, Patrick, Ludolph, Albert C., Danzer, Karin, and Weishaupt, Jochen H.
- Subjects
- *
MONOCYTES , *AMYOTROPHIC lateral sclerosis , *NEURODEGENERATION , *MOTOR neurons , *CD14 antigen , *ENZYME-linked immunosorbent assay - Published
- 2014
- Full Text
- View/download PDF
16. ArhGAP15, a RacGAP, Acts as a Temporal Signaling Regulator of Mac-1 Affinity in Sterile Inflammation.
- Author
-
Margraf, Andreas, Cappenberg, Anika, Vadillo, Eduardo, Ludwig, Nadine, Thomas, Katharina, Körner, Katharina, Zondler, Lisa, Rossaint, Jan, Germena, Giulia, Hirsch, Emilio, and Zarbock, Alexander
- Subjects
- *
LEUCOCYTES , *INFLAMMATION , *KIDNEY injuries , *NEUTROPHILS - Abstract
During inflammation, leukocyte recruitment has to be tightly controlled to prevent overwhelming leukocyte infiltration, activation, and, consequently, organ damage. A central regulator of leukocyte recruitment is Rac1. In this study, we analyzed the effects of the RacGAP ArhGAP15 on leukocyte recruitment. Using ArhGAP15-deficient mice, reduced neutrophil adhesion and transmigration in the TNF-a-inflamed cremaster muscle and a prolongation of chemokine-dependent leukocyte adhesion could be observed. In a murine model of sterile kidney injury, reduced neutrophil infiltration, and serum creatinine levels were apparent. Further in vitro and in vivo analyses revealed a defective intravascular crawling capacity, resulting from increased affinity of the b2-integrin Mac-1 after prolonged chemokine stimulation of neutrophils. LFA-1 activity regulation was not affected. Summarizing, ArhGAP15 specifically regulates Mac-1, but not LFA-1, and affects leukocyte recruitment by controlling postadhesion strengthening and intravascular crawling in a Mac-1-dependent manner. In conclusion, ArhGAP15 is involved in the time-dependent regulation of leukocyte postadhesion in sterile inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.